These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 8724540)

  • 61. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
    Fuertes Manuel J; Estorch Cabrera M; Camacho Martí V; Flotats Giralt A; Rodríguez-Revuelto AA; Hernández Fructuoso MA; Carrió Gasset I
    Rev Esp Med Nucl; 2006; 25(4):242-9. PubMed ID: 16827987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Magnetic resonance imaging and 67gallium scan in mediastinal malignant lymphoma: a prospective pilot study.
    Abrahamsen AF; Lien HH; Aas M; Winderen M; Hager B; Kvaløy S; Elgjo RF; Nome O
    Ann Oncol; 1994 May; 5(5):433-6. PubMed ID: 8075050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease.
    Karimjee S; Brada M; Husband J; McCready VR
    Eur J Cancer; 1992; 28A(11):1856-7. PubMed ID: 1389526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.
    Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hodgkin's lymphoma and radiotherapy].
    Datsenko PV; Panshin GA
    Vopr Onkol; 2015; 61(1):45-51. PubMed ID: 26016145
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
    Zinzani PL; Pileri S; Bendandi M; Buzzi M; Sabattini E; Ascani S; Gherlinzoni F; Magagnoli M; Albertini P; Tura S
    J Clin Oncol; 1998 Apr; 16(4):1532-7. PubMed ID: 9552063
    [TBL] [Abstract][Full Text] [Related]  

  • 71. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Santini G; Salvagno L; Leoni P; Chisesi T; De Souza C; Sertoli MR; Rubagotti A; Congiu AM; Centurioni R; Olivieri A; Tedeschi L; Vespignani M; Nati S; Soracco M; Porcellini A; Contu A; Guarnaccia C; Pescosta N; Majolino I; Spriano M; Vimercati R; Rossi E; Zambaldi G; Mangoni L; Rizzoli V
    J Clin Oncol; 1998 Aug; 16(8):2796-802. PubMed ID: 9704732
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of positron emission tomography (PET) in the management of lymphoma patients.
    Zinzani PL; Magagnoli M; Chierichetti F; Zompatori M; Garraffa G; Bendandi M; Gherlinzoni F; Cellini C; Stefoni V; Ferlin G; Tura S
    Ann Oncol; 1999 Oct; 10(10):1181-4. PubMed ID: 10586334
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
    Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
    Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
    [No Abstract]   [Full Text] [Related]  

  • 74. Residual masses on follow-up computed tomography in patients with mediastinal non-Hodgkin's lymphoma.
    Uematsu M; Kondo M; Tsutsui T; Murase T; Yorozu A; Hiramatsu H; Fujii H; Hashimoto S
    Clin Radiol; 1989 May; 40(3):244-7. PubMed ID: 2752680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
    Karmiris TD; Grigoriou E; Tsantekidou M; Spanou E; Mihalakeas H; Baltadakis J; Apostolidis J; Pagoni M; Karakasis D; Bakiri M; Mitsouli C; Harhalakis N; Nikiforakis E
    Leuk Lymphoma; 2003 Sep; 44(9):1523-8. PubMed ID: 14565654
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
    Pileri S; Bocchia M; Baroni CD; Martelli M; Falini B; Sabattini E; Gherlinzoni F; Amadori S; Poggi S; Mazza P
    Br J Haematol; 1994 Mar; 86(3):513-23. PubMed ID: 7519036
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP).
    Guglielmi C; Amadori S; Anselmo AP; Baroni CD; Biagini C; Cimino G; Papa G; Mandelli F
    Cancer Invest; 1987; 5(3):159-69. PubMed ID: 3651863
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.
    Ziegels P; Nocaudie M; Huglo D; Deveaux M; Detourmignies L; Wattel E; Marchandise X
    Eur J Nucl Med; 1995 Feb; 22(2):126-31. PubMed ID: 7758499
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
    Ceriani L; Martelli M; Gospodarowicz MK; Ricardi U; Ferreri AJ; Chiappella A; Stelitano C; Balzarotti M; Cabrera ME; Cunningham D; Guarini A; Zinzani PL; Giovanella L; Johnson PW; Zucca E
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):42-49. PubMed ID: 27839910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.